BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22913807)

  • 1. Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel.
    Maor Y; Morali G; Bashari D; Pénaranda G; Schapiro JM; Martinowitz U; Halfon P
    Haemophilia; 2013 Jan; 19(1):150-6. PubMed ID: 22913807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
    Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
    Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR
    Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
    Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
    Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
    Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
    Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.
    Lindh M; Lagging M; Arnholm B; Eilard A; Nilsson S; Norkrans G; Söderholm J; Wahlberg T; Wejstål R; Westin J; Hellstrand K
    J Viral Hepat; 2011 Jul; 18(7):e325-31. PubMed ID: 21692944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
    Ranjan P; Fletcher GJ; Radhakrishnan M; Sivakumar J; Premkumar PS; Goel A; Zachariah UG; Abraham P
    Indian J Med Microbiol; 2016; 34(3):335-41. PubMed ID: 27514956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
    Halfon P; Bourliere M; Ouzan D; Maor Y; Renou C; Wartelle C; Pénaranda G; Tran A; Botta D; Oules V; Castellani P; Portal I; Argiro L; Dessein A
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):931-5. PubMed ID: 21900787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus.
    Wong GL; Chan HL; Tse CH; Chan PO; Cheng JC; Cheng JS; Lau SH; Lee EK; Ma JM; Chan AW; Choi PC; Wong VW
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1040-8. PubMed ID: 25639146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
    Rao HY; Sun DG; Jiang D; Yang RF; Guo F; Wang JH; Liu F; Zhang HY; Zhang HH; Du SC; Jin Q; Qin H; Lok AS; Wei L
    J Viral Hepat; 2012 Mar; 19(3):173-81. PubMed ID: 22329371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
    New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
    Sarrazin C; Susser S; Doehring A; Lange CM; Müller T; Schlecker C; Herrmann E; Lötsch J; Berg T
    J Hepatol; 2011 Mar; 54(3):415-21. PubMed ID: 21112657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.
    Riva E; Scagnolari C; Monteleone K; Selvaggi C; Picardi A; Mazzarelli C; Pizzigallo E; Vincenzi B; Carducci A; Antonaci S; Giannelli G; Antonelli G
    J Viral Hepat; 2012 Sep; 19(9):650-3. PubMed ID: 22863269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of IL28B rs12979860 and rs8099917 Genotypes in Patients with Chronic Hepatitis C Virus Infection in Tianjin, China.
    Qiao K; Trieu C; Huo Z; Du Y; Hou W
    Clin Lab; 2018 Apr; 64(4):543-550. PubMed ID: 29739095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.
    Mangia A; Santoro R; Copetti M; Massari M; Piazzolla V; Spada E; Cappucci G; Missale G; Mottola L; Agostinacchio E; Mauro Ld; Zuccaro O; Maio P; Pellegrini F; Folgori A; Ferrari C
    J Hepatol; 2013 Aug; 59(2):221-8. PubMed ID: 23587473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4.
    Antaki N; Bibert S; Kebbewar K; Asaad F; Baroudi O; Alideeb S; Hadad M; Abboud D; Sabah H; Bochud PY; Negro F
    J Viral Hepat; 2013 Jan; 20(1):59-64. PubMed ID: 23231085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin.
    Lyoo K; Song MJ; Hur W; Choi JE; Hong SW; Kim CW; Bae SH; Choi JY; Choi SW; Shin EC; Yoon SK
    J Clin Virol; 2011 Dec; 52(4):363-6. PubMed ID: 21907615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.
    Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; García-Álvarez M; Resino S
    BMC Med; 2013 Jan; 11():6. PubMed ID: 23298311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.